3.74
1.58%
-0.06
Handel nachbörslich:
3.74
Schlusskurs vom Vortag:
$3.80
Offen:
$3.81
24-Stunden-Volumen:
494.59K
Relative Volume:
2.60
Marktkapitalisierung:
$187.48M
Einnahmen:
$81.06M
Nettoeinkommen (Verlust:
$-55.55M
KGV:
-2.5616
EPS:
-1.46
Netto-Cashflow:
$-47.98M
1W Leistung:
-18.52%
1M Leistung:
-37.35%
6M Leistung:
-29.96%
1J Leistung:
+66.22%
Sight Sciences Inc Stock (SGHT) Company Profile
Firmenname
Sight Sciences Inc
Sektor
Branche
Telefon
(415) 889-0550
Adresse
4040 CAMPBELL AVE,, MENLO PARK
Vergleichen Sie SGHT mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
SGHT | 3.74 | 187.48M | 81.06M | -55.55M | -47.98M | -1.46 |
ABT | 117.36 | 202.64B | 41.22B | 5.77B | 6.49B | 2.94 |
SYK | 389.40 | 150.72B | 21.97B | 3.59B | 3.21B | 6.74 |
BSX | 90.45 | 133.82B | 15.91B | 1.79B | 1.89B | 0.82 |
MDT | 87.59 | 112.98B | 32.58B | 3.93B | 5.15B | 2.71 |
EW | 69.89 | 40.52B | 6.60B | 4.16B | 490.10M | 2.34 |
Sight Sciences Inc Stock (SGHT) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2024-08-21 | Eingeleitet | Lake Street | Buy |
2023-09-12 | Herabstufung | BofA Securities | Neutral → Underperform |
2023-09-12 | Herabstufung | Piper Sandler | Overweight → Neutral |
2023-09-12 | Herabstufung | William Blair | Outperform → Mkt Perform |
2023-08-24 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
2023-07-10 | Herabstufung | Citigroup | Buy → Neutral |
2023-01-06 | Hochstufung | Stifel | Hold → Buy |
2022-10-04 | Eingeleitet | Needham | Hold |
2022-07-26 | Eingeleitet | Stifel | Hold |
2022-02-03 | Eingeleitet | William Blair | Outperform |
2022-01-07 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
Alle ansehen
Sight Sciences Inc Aktie (SGHT) Neueste Nachrichten
Sight Sciences, Inc. (NASDAQ:SGHT) Stocks Pounded By 26% But Not Lagging Industry On Growth Or Pricing - Simply Wall St
Sight Sciences FY2024 EPS Estimate Raised by William Blair - MarketBeat
Sight Sciences Announces New Leadership Appointments - Vision Monday
Sight Sciences price target lowered to $5 from $7 at Morgan Stanley - Yahoo Finance
Sight Sciences, Inc. (SGHT) Reports Q3 Loss, Misses Revenue Estimates - MSN
Sight Sciences (NASDAQ:SGHT) Price Target Lowered to $5.00 at Morgan Stanley - MarketBeat
Sight Sciences, Inc. (NASDAQ:SGHT) Q3 2024 Earnings Call Transcript - Insider Monkey
Sight Sciences Reports Third Quarter Results and Updates its Full Year 2024 Adjusted Operating Expense Guidance - Vision Monday
Sight Sciences Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
Sight Sciences stock price target cut on Q3 revenue headwinds - Investing.com
Sight Sciences (NASDAQ:SGHT) Receives "Neutral" Rating from Piper Sandler - MarketBeat
Sight Sciences' (SGHT) "Hold" Rating Reiterated at Needham & Company LLC - MarketBeat
Sight Sciences stock price target cut on Q3 revenue headwinds By Investing.com - Investing.com UK
Sight Sciences Inc. (SGHT) PT Lowered to $5.50 at Piper Sandler - StreetInsider.com
Sight Sciences, Inc. (SGHT) Misses Q3 EPS by 1c - StreetInsider.com
Sight Sciences Inc (SGHT) Q3 2024 Earnings Call Highlights: Navigating Challenges with ... By GuruFocus - Investing.com Canada
Sight Sciences Reports Modest Growth and Optimistic Outlook - TipRanks
Sight Sciences Appoints MK Raheja as Executive Vice President, Research and Development and Brenton Taylor as Executive Vice President, Operations - The Manila Times
Sight Sciences Reports Third Quarter 2024 Financial Results and Updates its Full Year 2024 Adjusted Operating Expense Guidance - The Manila Times
Sight Sciences Appoints MK Raheja as Executive Vice - GlobeNewswire
Sight Sciences Strengthens Leadership: Ophthalmic Innovation Expert & Inogen Co-Founder Join Executive Team | SGHT Stock News - StockTitan
Sight Sciences Q3: Revenue Up 1%, Cash Flow Turns Positive Despite Mixed Results | SGHT Stock News - StockTitan
Sight Sciences Inc (SGHT) Q3 2024 Earnings Report Preview: What To Expect - Yahoo Finance
Lake Street cuts Sight Sciences stock rating to hold amid market challenges - Investing.com Canada
Lake Street Capital Markets Downgrades Sight Sciences Inc. (SGHT) to Hold - StreetInsider.com
Sight Sciences (NASDAQ:SGHT) Rating Lowered to "Hold" at Lake Street Capital - MarketBeat
Rezolute, Inc. (NASDAQ:RZLT) Receives $11.57 Consensus Target Price from Analysts - Defense World
Global Dry Eye Disease Treatment Market Projected to Cross USD 9 Billion by 2030 | DelveInsight - The Malaysian Reserve
Sight Sciences (SGHT) Scheduled to Post Earnings on Thursday - MarketBeat
Analysts Estimate Tandem Diabetes Care, Inc. (TNDM) to Report a Decline in Earnings: What to Look Out for - MSN
Microsoft Co. (NASDAQ:MSFT) Shares Acquired by Parametrica Management Ltd - Defense World
KCK LTD.'s Strategic Reduction in NeuroPace Inc Shares - Yahoo Finance
KCK LTD. Adjusts Stake in NeuroPace Inc - GuruFocus.com
Preview: Zynex's Earnings - Benzinga
Sight Sciences CCO Matthew Link sells $244,900 in stock - Investing.com India
Sight Sciences, Inc. (NASDAQ:SGHT) Insider Sells $122,471.91 in Stock - MarketBeat
Sight Sciences CCO Matthew Link sells $244,900 in stock By Investing.com - Investing.com South Africa
The Manufacturers Life Insurance Company Increases Stock Holdings in Erasca, Inc. (NASDAQ:ERAS) - Defense World
The Manufacturers Life Insurance Company Buys New Position in Applied Optoelectronics, Inc. (NASDAQ:AAOI) - Defense World
The Manufacturers Life Insurance Company Invests $90,000 in TScan Therapeutics, Inc. (NASDAQ:TCRX) - Defense World
The Manufacturers Life Insurance Company Purchases Shares of 13,551 LifeMD, Inc. (NASDAQ:LFMD) - Defense World
The Manufacturers Life Insurance Company Invests $123,000 in Lincoln Educational Services Co. (NASDAQ:LINC) - Defense World
The Manufacturers Life Insurance Company Invests $102,000 in Backblaze, Inc. (NASDAQ:BLZE) - Defense World
Sight Sciences' IPO Lock-up Period Ends On Jan 11 - RTTNews
This Insider Has Just Sold Shares In Sight Sciences - Simply Wall St
Sight Sciences, Inc. (NASDAQ:SGHT) Insider Matthew Link Sells 20,734 Shares - MarketBeat
Sight sciences' chief commercial officer sells shares worth $244,878 - Investing.com
Sight sciences' chief commercial officer sells shares worth $244,878 By Investing.com - Investing.com UK
KCK LTD. Reduces Stake in NeuroPace Inc - GuruFocus.com
Sight Sciences to Report Third Quarter Financial Results on November 7, 2024 - The Manila Times
GenSight Biologics Announces LUMEVOQ® Scientific Updates at AAO 2024 - Yahoo Finance
Finanzdaten der Sight Sciences Inc-Aktie (SGHT)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):